ADRB2
ADRB2 (adrenoceptor beta 2, also known as beta-2 adrenergic receptor, B2AR, ADRBR, BAR, ARB2 or ADRB2R) is a G protein-coupled receptor for catecholamines. It couples to both G(s) and G(i) proteins and activates bifurcated signalling pathways. Browse Assay Genie's current range of ADRB2 research reagents below, or read on for the biology behind the target.
ADRB2 is a G protein-coupled receptor for catecholamines. It binds epinephrine with an approximately 30-fold greater affinity than norepinephrine, and couples to both G(s) and G(i) proteins. In the heart, epinephrine- and norepinephrine-activated ADRB2 induce rapid and slow cardiomyocyte contraction rate, respectively. Both ligands promote coupling to the G(s)/PKA pathway to regulate contraction rate, while epinephrine also promotes coupling to G(i) proteins. This G(i)/PI3K/Akt signalling is cardioprotective, especially under hypoxia and oxidative stress. ADRB2-G(s) signalling delivers proapoptotic signals in cardiomyocytes, although the G(i)-mediated survival effect appears to predominate. ADRB2 also signals independently of PKA to regulate cellular pH by modulating the Na(+)/H(+) exchanger SLC9A3.
The ADRB2 gene is intronless and encodes a member of the G protein-coupled receptor 1 family, adrenergic receptor subfamily. The receptor is found at the cell membrane and in the Golgi apparatus. It is directly associated with one of its effectors, the class C L-type calcium channel Ca(V)1.2. This receptor-channel complex also contains a G protein, an adenylyl cyclase, cAMP-dependent kinase and the counterbalancing phosphatase PP2A. This assembly ensures specific and rapid signalling.
ADRB2 is also a transcription regulator of the alpha-synuclein gene, and both genes are believed to be associated with risk of Parkinson's disease. Polymorphic forms, point mutations and downregulation of the gene are associated with nocturnal asthma, obesity, type 2 diabetes and cardiovascular disease. The HGNC groups it with the adrenoceptors, alongside ADRB1 and ADRB3.
ADRB2 regulates cardiomyocyte contraction rate through G(s)/PKA and mediates cardioprotective G(i)/PI3K/Akt signalling under hypoxia and oxidative stress.
Dual coupling to G(s) and G(i) makes ADRB2 a model for studying bifurcated signalling and receptor-channel complexes with Ca(V)1.2.
Variants and downregulation of ADRB2 are associated with nocturnal asthma, obesity and type 2 diabetes.
ADRB2 regulates transcription of the alpha-synuclein gene, and both genes are linked to Parkinson's disease risk.
ADRB2 is a catecholamine-binding G protein-coupled receptor that couples to G(s) and G(i). It regulates cardiomyocyte contraction rate, mediates cardioprotective G(i)/PI3K/Akt signalling, and modulates cellular pH through the Na(+)/H(+) exchanger SLC9A3 independently of PKA.
The HGNC name is adrenoceptor beta 2, and UniProt calls the protein beta-2 adrenergic receptor. Aliases include ADRBR, BAR, B2AR, ARB2 and ADRB2R. Earlier names include adrenergic, beta-2-, receptor, surface. The gene is intronless.
Mouse and rat both have an Adrb2 ortholog; check the datasheet of any product for its validated reactivity. In humans, polymorphisms, point mutations and downregulation are associated with nocturnal asthma, obesity, type 2 diabetes and cardiovascular disease.
Other beta adrenoceptors from the same HGNC adrenoceptor group with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P07550; product specifications from Assay Genie datasheets.